Literature DB >> 25577037

Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.

Jingli Xu1, Jianquan Yang1, Yubin Miao2.   

Abstract

INTRODUCTION: The aim of this study was to examine whether the substitution of the Lys linker with the aminooctanoic acid (Aoc) and polyethylene glycol (PEG) linker could substantially decrease the non-specific renal uptake of (99m)Tc-labeled Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone (α-MSH) hybrid peptides.
METHODS: The RGD motif {Arg-Gly-Asp-DTyr-Asp} was coupled to [Cys(3,4,10), D-Phe(7), Arg(11)]α-MSH₃₋₁₃ via the Aoc or PEG₂ linker to generate RGD-Aoc-(Arg(11))CCMSH and RGD-PEG-(Arg(11))CCMSH. The biodistribution results of (99m)Tc-RGD-Aoc-(Arg(11))CCMSH and (99m)Tc-RGD-PEG₂-(Arg(11))CCMSH were examined in M21 human melanoma-xenografted nude mice.
RESULTS: The substitution of Lys linker with Aoc and PEG₂ linker significantly reduced the renal uptake of (99m)Tc-RGD-Aoc-(Arg(11))CCMSH and (99m)Tc-RGD-PEG₂-(Arg(11))CCMSH by 58% and 63% at 2h post-injection. The renal uptake of (99m)Tc-RGD-Aoc-(Arg(11))CCMSH and (99m)Tc-RGD-PEG₂-(Arg(11))CCMSH was 27.93 ± 3.98 and 22.01 ± 9.89% ID/g at 2 h post-injection. (99m)Tc-RGD-Aoc-(Arg(11))CCMSH displayed higher tumor uptake than (99m)Tc-RGD-PEG₂-(Arg(11))CCMSH (2.35 ± 0.12 vs. 1.71 ± 0.25% ID/g at 2 h post-injection). The M21 human melanoma lesions could be clearly visualized by SPECT/CT using (99m)Tc-RGD-Aoc-(Arg(11))CCMSH as an imaging probe.
CONCLUSIONS: The favorable effect of Aoc and PEG₂ linker in reducing the renal uptake provided a new insight into the design of novel dual receptor-targeting radiolabeled peptides.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-melanocyte stimulating hormone hybrid peptide; Arg-Gly-Asp-conjugated; Dual receptor-targeting human melanoma imaging

Mesh:

Substances:

Year:  2014        PMID: 25577037      PMCID: PMC4361317          DOI: 10.1016/j.nucmedbio.2014.11.002

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  22 in total

1.  A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

Authors:  Sylvie Froidevaux; Martine Calame-Christe; Heidi Tanner; Lazar Sumanovski; Alex N Eberle
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

2.  99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.

Authors:  Yubin Miao; Katherine Benwell; Thomas P Quinn
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

3.  Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.

Authors:  R Haubner; H J Wester; U Reuning; R Senekowitsch-Schmidtke; B Diefenbach; H Kessler; G Stöcklin; M Schwaiger
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

4.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.

Authors:  S M Albelda; S A Mette; D E Elder; R Stewart; L Damjanovich; M Herlyn; C A Buck
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma.

Authors:  Haixun Guo; Yubin Miao
Journal:  Mol Pharm       Date:  2012-07-19       Impact factor: 4.939

6.  203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.

Authors:  Yubin Miao; Said D Figueroa; Darrell R Fisher; Herbert A Moore; Richard F Testa; Timothy J Hoffman; Thomas P Quinn
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

7.  111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.

Authors:  Yubin Miao; Fabio Gallazzi; Haixun Guo; Thomas P Quinn
Journal:  Bioconjug Chem       Date:  2008-01-16       Impact factor: 4.774

8.  In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy.

Authors:  Yubin Miao; Nellie K Owen; Donna Whitener; Fabio Gallazzi; Timothy J Hoffman; Thomas P Quinn
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

9.  In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.

Authors:  Jesse J Parry; Thomas S Kelly; Rebecca Andrews; Buck E Rogers
Journal:  Bioconjug Chem       Date:  2007-05-16       Impact factor: 4.774

10.  64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.

Authors:  Zhen Cheng; Zhengming Xiong; Murugesan Subbarayan; Xiaoyuan Chen; Sanjiv Sam Gambhir
Journal:  Bioconjug Chem       Date:  2007-03-10       Impact factor: 4.774

View more
  5 in total

Review 1.  PET and SPECT imaging of melanoma: the state of the art.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quanyong Luo; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-30       Impact factor: 9.236

2.  Plasmonic Nanoparticles with Quantitatively Controlled Bioconjugation for Photoacoustic Imaging of Live Cancer Cells.

Authors:  Chao Tian; Wei Qian; Xia Shao; Zhixing Xie; Xu Cheng; Shengchun Liu; Qian Cheng; Bing Liu; Xueding Wang
Journal:  Adv Sci (Weinh)       Date:  2016-09-07       Impact factor: 16.806

Review 3.  Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.

Authors:  Chengcheng Zhang; Kuo-Shyan Lin; François Bénard
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

4.  18F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography.

Authors:  Chengcheng Zhang; Zhengxing Zhang; Helen Merkens; Jutta Zeisler; Nadine Colpo; Navjit Hundal-Jabal; David M Perrin; Kuo-Shyan Lin; François Bénard
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

5.  Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.

Authors:  Ayoung Pyo; Dong-Yeon Kim; Heejung Kim; Daejin Lim; Seong Young Kwon; Sae-Ryung Kang; Hyung-Seok Kim; Hee-Seung Bom; Jung-Joon Min
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-21       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.